加载中
NASDAQConsumer DefensiveTobacco
最新数据
US$0.6674
−US$0.057 · -7.87%
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
常规交易时段
US$0.6674
−US$0.057 · -7.87%
盘中时间采用ET。市场数据可能有所延迟。
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
日内区间
当前US$0.6674
52周区间
当前US$0.6674
盘中时间采用ET。市场数据可能有所延迟。
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
日内区间
当前US$0.6674
52周区间
当前US$0.6674
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 704.9万 USD | 1187.8万 USD | 3220.4万 USD | 4050.1万 USD | 3094.8万 USD |
| 销货成本 | 1018.6万 USD | 1427.8万 USD | 4090万 USD | 3865.4万 USD | 2946.2万 USD |
| 毛利 | −313.7万 USD | −240万 USD | −869.6万 USD | 184.7万 USD | 148.6万 USD |
| 研究与开发 | 68.8万 USD | 113.3万 USD | 264.4万 USD | 357.8万 USD | 391.2万 USD |
| 销售、一般及管理费用 | 759.1万 USD | 1028.7万 USD | 3182.7万 USD | 3223.1万 USD | 2590.8万 USD |
| 营业费用 | 827.9万 USD | 1155万 USD | 3623.5万 USD | 3548.2万 USD | 2989.8万 USD |
| 利息收入 | 8.3万 USD | 7.2万 USD | 21.9万 USD | 31.3万 USD | 32.1万 USD |
| 利息支出 | 145.5万 USD | 209.4万 USD | 936.6万 USD | 5.5万 USD | 5.8万 USD |
| 折旧和摊销 | 115.7万 USD | 125.8万 USD | 485.9万 USD | 359.1万 USD | 153.6万 USD |
| 营业利润 | −1141.6万 USD | −1395万 USD | −4493.1万 USD | −3363.5万 USD | −2841.2万 USD |
| 净利润 | −505.4万 USD | −1516.4万 USD | −1.41亿 USD | −5980.1万 USD | −3260.9万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
